NonValvular Atrial Fibrillation Clinical Trial
Official title:
Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
The primary objectives of this study are: - To estimate the incidence rate of unexpected adverse events - To characterize the bleeding events and assess risk factors of bleeding - To identify ancillary baseline variables that may also be associated with adverse outcomes
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04586972 -
Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
|
||
| Completed |
NCT02674594 -
Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US
|
N/A | |
| Recruiting |
NCT04494347 -
Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)
|
N/A | |
| Not yet recruiting |
NCT04942873 -
The Adherence to Oral Anticoagulant in Chinese Patients With NVAF
|
||
| Recruiting |
NCT05731882 -
First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder
|
N/A | |
| Completed |
NCT01885598 -
Eliquis Regulatory Post Marketing Surveillance
|
N/A | |
| Completed |
NCT02919982 -
Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
|
||
| Completed |
NCT00684307 -
Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
|
Phase 2 | |
| Recruiting |
NCT04073316 -
AntiCoagulants and COGnition
|
Phase 4 | |
| Completed |
NCT03374540 -
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
|
||
| Recruiting |
NCT05715658 -
Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects
|
N/A |